Core Viewpoint - Verano Holdings Corp. is expanding its retail presence in Connecticut with the opening of Zen Leaf Enfield, increasing its total dispensary count to 157 nationwide, and actively engaging in community development projects [1][2][5]. Group 1: Company Expansion - Zen Leaf Enfield will officially open on May 23, 2025, marking the seventh retail location for Verano in Connecticut [1]. - The company now operates 157 dispensaries across the United States and has 15 cultivation and processing facilities with over 1.1 million square feet of cultivation capacity [5][9]. Group 2: Community Engagement - Verano is supporting the Thompsonville Fire Department by providing funds for a year's supply of Narcan to aid in combating the opioid crisis [3][5]. - The company is also involved in local charitable initiatives, including a food donation drive for Enfield Loaves and Fishes and Enfield Food Shelf [3][5]. Group 3: Grand Opening Activities - The Grand Opening celebration will feature various activities, including a ceremonial ribbon cutting with community leaders and local partners [6][7]. - Special promotions will be available during the opening weekend, including discounts on cannabis products and complimentary food from local vendors [6][8]. Group 4: Local Economic Development - Zen Leaf Enfield is strategically located near the Enfield Square Mall, which is undergoing a $250 million redevelopment into the Enfield Marketplace, aimed at boosting local economic growth [2][5]. - The company aims to contribute to the long-term success of the Enfield community by investing in local job opportunities [2].

Core Viewpoint - Investing in stocks during market volatility requires a balanced strategy that focuses on growth, dividends, and stability to appeal to long-term investors while managing overall risk Group 1: Dividend Stocks - Allocating $5,000 to a top dividend stock can provide valuable recurring income, which can enhance overall returns and support day-to-day financial needs without liquidating other investments [3][5] - Enbridge (ENB) is highlighted as a strong dividend stock, offering a yield of 6%, significantly higher than the S&P 500 average of 1.3%, resulting in $300 per year in dividends from a $5,000 investment [4][5] - Enbridge has a track record of increasing its dividend for 30 consecutive years, indicating strong financial performance and the likelihood of continued dividend growth in the future [6] Group 2: Growth Stocks - A significant investment of $4,000 is recommended for a growth stock, with Alphabet (GOOG) identified as a suitable option due to its strong assets in YouTube and Google Search, along with heavy investments in artificial intelligence [7][8] - Despite facing antitrust concerns and a 12% decline in stock price in 2025, Alphabet's valuation at 19 times trailing earnings and its generation of $75 billion in free cash flow over the past 12 months presents a compelling investment opportunity [9][10] Group 3: Riskier Investments - The remaining $1,000 can be allocated to a riskier stock with high upside potential, such as Green Thumb Industries (GTBIF), a cannabis company with significant future value potential [11] - Green Thumb operates in 14 states with over 100 retail stores, and potential nationwide marijuana legalization could greatly benefit the company by improving access to funding and market efficiency [12][13] - Although Green Thumb has lost more than half of its value in the past three years due to industry challenges and skepticism about legalization, it remains one of the safer cannabis investments, making it a candidate for a modest position in a diversified portfolio [13][14]

Core Viewpoint - Glass House Brands Inc. is implementing a long-term management incentive plan that includes performance-based restricted stock units (RSUs) for key executives, aimed at aligning their interests with those of shareholders and driving long-term value creation [1][2][6]. Group 1: Management Incentive Plan - The Board of Directors approved a long-term management incentive plan on May 15, 2025, granting performance-based RSUs to key executives, which will vest based on achieving specific share price milestones [2][5]. - The performance-based RSUs will vest over a five-year period, contingent upon the company achieving a minimum share price of $30.00, with additional vesting if the price reaches or exceeds $60.00 [2][3]. - A total of 3,000,000 performance-based RSUs were granted, representing approximately 2.3% of the fully diluted share count as of May 14, 2025 [3]. Group 2: Shareholder Alignment and Governance - The Performance Awards are designed to align the interests of shareholders, the company, and the recipients, encouraging retention of key executives and promoting the achievement of strategic and financial objectives [6][7]. - A special committee of independent directors was established to assess the efficacy of the Performance Awards, ensuring they are in the best interests of the company [5]. - The Board adopted a clawback policy to recover any proceeds from the Performance Awards in the event of financial restatements, consistent with best governance practices [7]. Group 3: Company Overview - Glass House Brands is recognized as one of the fastest-growing, vertically integrated cannabis companies in the U.S., focusing on the California market and building strong brands [8][9]. - The company operates a range of brands and retail dispensaries, emphasizing sustainable practices and community respect [9].

Steve McLean Named Interim Chief Financial OfficerLAS VEGAS, May 20, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced that Dennis Logan, the Chief Financial Officer of the Company, submitted his resignation effective May 31, 2025. Mr. Logan will be leaving the Company to pursue other opportunities. Mr. Logan has served as the Chief Financial Officer of the Company since 20 ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Canopy Growth Corporation securities between May 30, 2024, and February 6, 2025, of the upcoming lead plaintiff deadline on June 3, 2025 [1] Group 1: Class Action Details - Investors who purchased Canopy Growth securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6] - The lawsuit alleges that Canopy Growth made false and misleading statements regarding its financial health and cost management, which negatively impacted investors when the truth was revealed [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4] - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements [4]

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that negatively impacted investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding the costs associated with the production of Claybourne pre-rolled joints and Storz & Bickel vaporizer devices, which were likely to adversely affect the company's gross margins and overall financial results [2]. - It is alleged that the defendants overstated the effectiveness of Canopy's cost reduction measures and misrepresented the health of its gross margins while downplaying existing issues [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Canopy Growth Corporation regarding a class action lawsuit due to alleged misleading statements and undisclosed costs impacting the company's financial performance [1][2]. Allegations - The complaint alleges that Canopy Growth incurred significant costs related to the production of Claybourne pre-rolled joints during its product launch in Canada [1]. - It is claimed that these costs, along with indirect costs from Storz & Bickel vaporizer devices, negatively affected the company's gross margins and overall financial results [1]. - The defendants are accused of overstating the effectiveness of Canopy's cost reduction measures and the health of its gross margins while downplaying existing issues [1]. - As a result, the public statements made by the defendants are considered materially false and misleading throughout the relevant period [1]. Class Action Details - The class period for the lawsuit is from May 30, 2024, to February 6, 2025, and shareholders are encouraged to register by June 3, 2025, to participate [2]. - Registered shareholders will receive updates through a portfolio monitoring software regarding the case's progress [2]. Law Firm's Mission - The Gross Law Firm aims to protect investors' rights who have suffered losses due to deceit, fraud, and illegal business practices [3]. - The firm is committed to ensuring companies engage in responsible business practices and good corporate citizenship [3].

Group 1 - Cronos (NASDAQ: CRON) reported increasing revenues and net income for Q1-2025, with both international and domestic sales on the rise [1] - The company's stock has increased by 25% over the last month and is up 6.5% since the last coverage in March [1] - The report is part of a monthly analysis on the cannabis industry, highlighting the analyst's expertise in technical stock analysis and emerging markets [1]

Core Insights - Ayurcann Holdings Corp. reported record-breaking financial results for the three months ended March 31, 2025, showcasing exceptional growth and operational excellence in the cannabis industry [1][2] Financial Performance - Gross revenue for Q3 2025 reached $14,179,974, marking a 22% year-over-year increase from $11,655,360 in Q3 2024 [8] - Positive adjusted EBITDA of $766,742 at the operating subsidiary level and $342,634 on a consolidated basis, with a gross margin of 38% [8] - Consistent gross margins and a disciplined cost structure support sustainable profitability and future shareholder value [6] Market Position - Ayurcann is recognized as a Top 3 vape producer in Ontario by volume, holding a 5% share of the national vape market and an 8% share in Ontario [8] - The company has established itself as one of Canada's most efficient and scalable cannabis producers, with strong market share and growing brand recognition [8] Product Development and Expansion - Over the last six months, Ayurcann launched 25 new SKUs across vapes, pre-rolls, and concentrates, enhancing its product portfolio [8] - The company is actively expanding into additional provinces and retail channels across Canada, which is expected to drive continued revenue growth [7][8] - Ayurcann is scaling its pre-rolls and concentrates to tap into growing consumer segments in the cannabis market [8] Operational Efficiency - The company's lean, high-throughput manufacturing model enables it to maintain strong gross margins and positive cash flow in a competitive pricing environment [8] - Ayurcann's products are now available nationwide, positioning the company as a reliable national supplier to retailers [8]

VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, is pleased to announce that it will be reporting its financial results for the three months ended March 31, 2025 (“Q1 2025”) after market close on Tuesday, May 27, 2025. The Company will be hosting a conference call to discuss Q1 2025 results on Wednesday, ...